Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:EXAM

(EXAM) (EXAM) Stock Price, News & Analysis

(EXAM) logo

About (EXAM) Stock (NYSE:EXAM)

Advanced Chart
Remove Ads

Key Stats

Today's Range
$35.05
$35.17
50-Day Range
N/A
52-Week Range
$21.98
$37.26
Volume
3.56 million shs
Average Volume
660,679 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

ExamWorks Group, Inc. is a provider of independent medical examinations (IMEs), peer reviews, bill reviews, Medicare compliance, case management and other related services (IME services or the IME industry). The Company conducts its business through four geographic segments, namely, the United States, Canada, the United Kingdom and Australia. The Company provides IME services through its medical panel of credentialed physicians and other medical providers. Its clients include property and casualty insurance carriers, law firms, third-party claim administrators and government agencies that use independent services to confirm the veracity of claims by sick or injured individuals and to facilitate care for workers' compensation, automotive, personal injury liability and disability insurance coverage. The Company also provides a range of services, including Medicare compliance services, bill review services and case management services.

Remove Ads
Receive EXAM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (EXAM) and its competitors with MarketBeat's FREE daily newsletter.

EXAM Stock News Headlines

Why Elon Musk Is Investigating Fort Knox
With gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulate more of the precious metal, the timing couldn't be more critical. If the gold reserves in Fort Knox are found to be less than officially reported, we could see gold prices skyrocket virtually overnight.
See More Headlines

EXAM Stock Analysis - Frequently Asked Questions

(EXAM) (NYSE:EXAM) issued its quarterly earnings data on Tuesday, May, 10th. The business services provider reported $0.08 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.08. The company's revenue for the quarter was up 15.4% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that (EXAM) investors own include Bristol-Myers Squibb (BMY), Ciena (CIEN), Best Buy (BBY), China Biologic Products (CBPO), Community Health Systems (CYH), Diplomat Pharmacy (DPLO) and Energy Transfer (ET).

Company Calendar

Last Earnings
5/10/2016
Today
4/02/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
N/A
Industry
N/A
Sub-Industry
Health Care Services
Current Symbol
NYSE:EXAM
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NYSE:EXAM) was last updated on 4/2/2025 by MarketBeat.com Staff
From Our Partners